Cancer evolves over time, with different sub clones acquiring new mutations that help the tumour grow and resist treatment. Our mission is to unravel and target the mechanisms driving tumour evolution through cutting-edge single-cell methodologies and computational approaches. Ultimately, we aim to identify new therapeutic targets with the vision of improving long-term survival in cancer patients.
Antonio Lentini
Assistant Professor
Wallenberg & SciLifeLab DDLS Fellow in Precision medicine, Group Leader at the Department of Biomedical and Clinical Sciences